Balance Sheet Data

Clovis Oncology, Inc. (CLVS)

$ 3.2
-0.14 (-4.19%)

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 266.18563.73520.15296.66240.2320,213,936.073,618,534,635.78647,760,676,959.37115,956,854,596,900.1320,757,654,186,609,328
Total Cash (%)
Account Receivables 3.378.2115.1634.6630.60258,594.4746,291,481.178,286,724,930.751,483,422,183,622.05265,550,189,399,450.06
Account Receivables (%)
Inventories -27.5127.0726.5230.718,478.151,517,689.26271,684,402.4648,634,734,822.348,706,195,165,513.02
Inventories (%)
Accounts Payable 10.9115.1528.5232.2426.69829,686.49148,523,736.0826,587,512,766.974,759,480,563,848.26852,003,549,041,522.25
Accounts Payable (%)
Capital Expenditure -0.77-4.10-64.24-19.04-8.35-63,331.14-11,337,026.40-2,029,462,375.14-363,297,868,973.28-65,034,633,416,841.59
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.